Although exploratory in nature, this study raises the hypothesis that several metabolites, related to defective β-cell secretory function including adiponectin, glutamine, insulin secretory index HOMA-β%, pyruvate and gGT may contribute to improved GDM risk assessment in women with obesity. The gene discussed is ADIPOQ; the disease is obesity disorder.